BCR-ABL1 Compound Mutations Combining Key Kinase Domain Positions Confer Clinical Resistance to Ponatinib in Ph Chromosome-Positive LeukemiaMatthew S. Zabriskie, Thomas O’Hare, Johanna Estrada et al.|Cancer Cell|2014Cited by 366
Genomic landscape of neutrophilic leukemias of ambiguous diagnosisHaijiao Zhang, Jeffrey Tyner, Beth Wilmot et al.|Blood|2019Cited by 84